Antibody-based medicines are playing an ever increasing role in the arsenal of treatments of many diseases, from cancer to obesity to Alzheimer’s. Cell surface proteins, called membrane receptors, are considered key therapeutic targets in many of these pathologies, yet targeting them with antibodies has proven to be a challenge. Amgen British Columbia is dedicated to […]
Read More